Literature DB >> 871915

Release of [3H]acetylcholine from rat hippocampal slices: effect of septal lesion and of graded concentrations of muscarnic agonists and antagonists.

J C Szerb, P Hadházy, J D Dudar.   

Abstract

To establish the existence and sensitivity of presynaptic muscarinic receptors on central cholinergic neurons, the electrically evoked release of [3H]ACh from hippocampal slices was measured after medial septal lesion or in the presence of graded concentrations of muscarinic agonists and antagonists. One week after septal lesion, the evoked release of [3H]ACh was abolished, indicating that septo-hippocampal cholinergic fibres are the source of this release. The muscarinic agonists, Oxotremorine, carbamylcholine and arecoline reduced the rate of evoked release of [3H]ACh with an ED50 similar to the ED50 required to displace specific [3H]quinuclidinyl benzilate (QNB) binding as found by Yamamura and Snyder. However, the antagonists QNB, antropine and scopolamine were 10 times weaker in increasing the rate of [3H]ACh release than in displacing [3H]QNB binding. Results suggest that the lower affinity of muscarinic antagonists to presynaptic receptors prevents the demonstration of the specific labelling of these receptors with [3H]QNB.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 871915     DOI: 10.1016/0006-8993(77)90995-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

1.  Activation of dopamine D1 receptors does not affect D2 receptor-mediated inhibition of acetylcholine release in rabbit striatum.

Authors:  V Dolezal; R Jackisch; G Hertting; C Allgaier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-01       Impact factor: 3.000

2.  Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studies.

Authors:  G Fisone; C F Wu; S Consolo; O Nordström; N Brynne; T Bartfai; T Melander; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

3.  The inhibition of cerebral high affinity receptor sites by lead and mercury compounds.

Authors:  S C Bondy; A K Agrawal
Journal:  Arch Toxicol       Date:  1980-12       Impact factor: 5.153

4.  Effect of low calcium and of oxotremorine on the kinetics of the evoked release of [3H]acetylcholine from the guinea-pig myenteric plexus; comparison with morphine.

Authors:  J C Szerb
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-03       Impact factor: 3.000

5.  Role of dopamine receptors in the modulation of acetylcholine release in the rabbit hippocampus.

Authors:  H Strittmatter; R Jackisch; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-12       Impact factor: 3.000

Review 6.  Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release.

Authors:  R Quirion
Journal:  J Psychiatry Neurosci       Date:  1993-11       Impact factor: 6.186

7.  Muscarine receptors on the rat phrenic nerve, evidence for positive and negative muscarinic feedback mechanisms.

Authors:  I Wessler; M Karl; M Mai; A Diener
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

8.  Alteration of acetylcholine synthesis in mouse brain cortex in mild hypoxic hypoxia.

Authors:  M Shimada
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

9.  Failure of muscarinic blockade to antagonize analepsis induced by thyrotropin-releasing hormone and MK-771 in the rat.

Authors:  E M Santori; D E Schmidt; P W Kalivas; A Horita
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

10.  Presynaptic muscarinic receptors inhibiting active acetylcholine release in the bullfrog sympathetic ganglion.

Authors:  K Koketsu; M Yamada
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.